Pfizer

Verily lures major pharmas with promise of speedier clinical research
Verily lures major pharmas with promise of speedier clinical research
BioPharma Dive
Verily
Alphabet
clinical trials
Pfizer
Novartis
Sanofi
Otsuka
Flag link:
Where Will Pfizer Be in 5 Years?
Where Will Pfizer Be in 5 Years?
Motley Fool
Pfizer
M&A
spin-offs
dividends
Flag link:
EMA imposes formal limit on Xeljanz prescription as regulators continue to review safety concerns
EMA imposes formal limit on Xeljanz prescription as regulators continue to review safety concerns
Endpoints
EMA
Pfizer
Europe
Xeljanz
post-marketing studies
Flag link:
Pfizer’s blood clot drug Fragmin gets FDA approval for pediatric patients
Pfizer’s blood clot drug Fragmin gets FDA approval for pediatric patients
Pharmaceutical Business Review
Pfizer
FDA
Fragmin
blood clots
pediatrics
Flag link:
Pfizer’s Abrocitinib yields positive results in phase 3 moderate to severe AD trial
Pfizer’s Abrocitinib yields positive results in phase 3 moderate to severe AD trial
Pharmaceutical Business Review
Pfizer
clinical trials
PF-04965842
atopic dermatitis
Flag link:
Merck and Pfizer’s Bavencio approved for renal cell carcinoma
Merck and Pfizer’s Bavencio approved for renal cell carcinoma
Pharmaforum
Merck KGaA
Pfizer
Bavencio
FDA
Inlyta
advanced renal cell carcinoma
Flag link:
Pfizer jumps into the heated PhIII race for new-wave JAK inhibitors — but safety frets loom large
Pfizer jumps into the heated PhIII race for new-wave JAK inhibitors — but safety frets loom large
Endpoints
Pfizer
JAK inhibitors
abrocitinib
anti-inflammatories
Flag link:
Pfizer selects first GPCR candidate from Sosei Heptares tie-up
Pfizer selects first GPCR candidate from Sosei Heptares tie-up
Pharmaforum
Pfizer
Sosei Heptares
drug development
R&D
GPCRs
Flag link:
[video]Top vaccine makers Merck and Pfizer target China and older adults next
[video]Top vaccine makers Merck and Pfizer target China and older adults next
Yahoo/CNBC
vaccines
Merck
Pfizer
Sanofi Pasteur
GSK
China
Flag link:
How Viagra revolutionized the erectile dysfunction market
How Viagra revolutionized the erectile dysfunction market
CNBC
Pfizer
Viagra
generics
erectile dysfunction
Flag link:
Why dwarfism start-up Therachon picked Pfizer takeout over IPO
Why dwarfism start-up Therachon picked Pfizer takeout over IPO
BioCentury
Pfizer
Therachon
IPOs
Flag link:
Looking to topple Pfizer's Prevnar 13 dynasty, Merck claims another win for its 'breakthrough' pneumococcal conjugate vaccine
Looking to topple Pfizer's Prevnar 13 dynasty, Merck claims another win for its 'breakthrough' pneumococcal conjugate vaccine
Endpoints
Merck
Pfizer
vaccines
pneumococcal disease
V114
Prevnar 13
FDA
Flag link:
Pfizer agrees on $340M upfront to buy Therachon for dwarfism drug
Pfizer agrees on $340M upfront to buy Therachon for dwarfism drug
Fierce Biotech
Pfizer
Therachon
short-limbed dwarfism
M&A
Flag link:
Can Pfizer Leap Over the Competition With This Potential Blockbuster?
Can Pfizer Leap Over the Competition With This Potential Blockbuster?
Motley Fool
Pfizer
Vyndamax
tafamidis
ATTR
Alnylam
Onpattro
Akcea Therapeutics
Tegsedi
Eidos Therapeutics
AG10
Flag link:
Pfizer Calls for Compromise on Retroactively Using Suffixes in Biologic Names
Pfizer Calls for Compromise on Retroactively Using Suffixes in Biologic Names
RAPS.org
Pfizer
FDA
suffixes
drug names
biologics
biosimilars
Flag link:
Insurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For It
Insurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For It
Forbes
Pfizer
tafamidis
insurers
PBMs
ATTR
Flag link:
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
Xconomy
FDA
Pfizer
tafamidis
Vyndaqel
Vyndamax
ATTR
Alnylam
Akcea
Flag link:
ED Drug Shows Promise in Sheep Heart Failure Study
ED Drug Shows Promise in Sheep Heart Failure Study
BioSpace
heart failure
tadalafil
Pfizer
Viagra
Eli Lilly
Cialis
Flag link:
Pfizer prospects for tafamidis market
Pfizer prospects for tafamidis market
Biopharma Dive
Pfizer
tafamidis
transthyretin amyloid cardiomyopathy
Flag link:
Pfizer posts earnings beat, raises 2019 profit forecast
Pfizer posts earnings beat, raises 2019 profit forecast
Yahoo/Reuters
Pfizer
earnings
Flag link:

Pages